HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Significant Decline in Short Interest

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 1,300 shares, a drop of 92.1% from the February 29th total of 16,500 shares. Based on an average trading volume of 11,900 shares, the days-to-cover ratio is presently 0.1 days.

HAVN Life Sciences Stock Performance

OTCMKTS:HAVLF remained flat at $0.02 on Thursday. 41 shares of the company’s stock traded hands, compared to its average volume of 7,258. HAVN Life Sciences has a 52-week low of $0.01 and a 52-week high of $0.15. The firm’s 50-day simple moving average is $0.02 and its two-hundred day simple moving average is $0.02.

About HAVN Life Sciences

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.